Target intelligence / Profile preview

Divalent and heavy metal ions

Molecular classification
Other
01

Overview

Divalent and heavy metal ions represent a diverse group of chemical entities that serve as the primary targets for chelation therapy in cases of acute or chronic poisoning (NIH: Heavy Metal Toxicity). These ions include essential elements like copper and iron, which can become toxic in overload states, as well as non-essential toxic metals such as lead, mercury, and cadmium (StatPearls: Chelation Therapy). In biological systems, these ions often exert toxicity by binding to sulfhydryl groups on proteins, displacing essential metal cofactors from enzymes, or inducing oxidative stress through the Fenton reaction (PubMed: Metal Toxicity Mechanisms). Therapeutic agents, known as chelators, interact with these ions by forming stable, multi-dentate coordination complexes that neutralize the metal's reactivity and enhance its renal or biliary clearance (PubChem: Chelating Agents). Targeting these ions is critical in managing conditions like Wilson's disease, hemochromatosis, and environmental lead exposure. However, pharmacological intervention must be carefully managed to avoid the depletion of essential divalent cations like calcium and zinc, which are vital for normal physiological function.

Other names
Heavy metalsDivalent cationsToxic metalsMetal ions
02

Mechanism of action

Chelating agents act as polydentate ligands that form stable, ring-like coordination complexes with divalent and heavy metal ions, effectively sequestering them from biological ligands and facilitating their excretion from the body (StatPearls: Chelation Therapy).

03

Biological functions

Other
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

NephrotoxicityEssential mineral depletionHypersensitivityMetal redistribution
06

Interacting drugs

Edetate calcium disodium

7 more in the full profile.

07

Biomarkers

Blood lead levelSerum ferritinUrinary metal excretionCeruloplasmin

Beyond the preview

Go deeper on Divalent and heavy metal ions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Divalent and heavy metal ions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call